Craniosynostosis

panel craniosynostosis (FGFR1 (ex7), FGFR2, GFR3 (ex6), TWIST1) ¹

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

Turnaround time
8 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries

Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA

---

FGFR1 (exon 7) - craniosynostosis ¹

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of selected exons and flanking intron-exon boundaries

Remarks
Regarding FGRF1 sequencing only a targetted amplicon (exon 7) will be analysed

OMIM: 136350
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---

FGFR2 - craniosynostosis ¹

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

This product is also part of the following panels:

• Craniofacial anomalies panel
• Disorders/differences of sex development (DSD) / Primary adrenal insufficiency panel
• Intellectual disability panel
• Mendelian inherited disorders panel
• Orofacial clefting panel
• panel craniosynostosis (FGFR1 (ex7), FGFR2, GFR3 (ex6), TWIST1) ¹
• Short stature/skeletal dysplasia panel
• Skin disorders panel¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries
• Deletion/duplication analysis (MLPA)

OMIM: 176943
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---

FGFR3 (exon 6) - craniosynostosis ¹

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of selected exons and flanking intron-exon boundaries
• Deletion/duplication analysis (MLPA)

Remarks
Regarding sequencing for FGFR3 only a targetted amplicon (exon 6) will be analysed.

OMIM: 134934
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---

TCF12 - craniosynostosis, type 3

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

This product is also part of the following panels:

• Craniofacial anomalies panel
• Disorders/differences of sex development (DSD) / Primary adrenal insufficiency panel
• Hypogonadotropic hypogonadism (Kallmann) panel
• Mendelian inherited disorders panel
• Short stature/skeletal dysplasia panel

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600480
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---

TWIST1 - craniosynostosis ¹

This test is available for the following conditions:

• Conditions > Skeletal > Craniosynostosis

This product is also part of the following panels:

• Craniofacial anomalies panel
• Intellectual disability panel
• Mendelian inherited disorders panel
• Orofacial clefting panel
• panel craniosynostosis (FGFR1 (ex7), FGFR2, GFR3 (ex6), TWIST1) ¹
• Short stature/skeletal dysplasia panel

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries
• Deletion/duplication analysis (MLPA)

OMIM: 601622
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---